Oral Semaglutide

The Peptide Podcast · Jan 1, 2026 · 6m

Today, we're diving into an exciting development in obesity treatment—oral semaglutide.

Last week, the FDA approved Novo Nordisk's Wegovy pill as the first and only oral GLP-1 for weight loss in adults. This approval is based on results from the OASIS-4 phase 3 clinical trial showing that a once-daily oral version of semaglutide can deliver nearly the same weight loss results as the injectable form.

So, what does that really mean for patients and treatment options? Let's break it down.

Read the Full Episode Transcript:

https://pepties.com/oral-semaglutide/

Dr. Nikki's Qualifications…